Confo Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Confo Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11012
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Confo Therapeutics is a drug discovery company that conducts research and development of g protein coupled receptors targeted therapeutics. The company offers CONFO body technology. Its technology uses confobody stabilized functional conformations of g protein coupled receptors. Confo Therapeutics stabilizes the druggable signaling conformation of g protein coupled receptors targeting to enable screening for pathway selective agonists, enable structure-based drug design and develop a pipeline of agonist drugs against selected high value g protein coupled receptors. The company’s CONFO body technology recognizes discontinuous amino acid segments on native proteins. It operates offices in Ghent and Brussels, Belgium. Confo Therapeutics is headquartered in Brussels, Belgium.

Confo Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Confo Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Confo Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Confo Therapeutics Raises USD7.3 Million Financing 10
Confo Therapeutics Raises USD3.37 million in Venture Financing 12
Partnerships 13
Confo Therapeutics Enters into Agreement with H. Lundbeck 13
Licensing Agreements 14
Roche Enters into Licensing Agreement with Confo Therapeutics 14
Equity Offering 15
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 15
Confo Therapeutics – Key Competitors 16
Confo Therapeutics – Key Employees 17
Confo Therapeutics – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Confo Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Confo Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Confo Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Confo Therapeutics Raises USD7.3 Million Financing 10
Confo Therapeutics Raises USD3.37 million in Venture Financing 12
Confo Therapeutics Enters into Agreement with H. Lundbeck 13
Roche Enters into Licensing Agreement with Confo Therapeutics 14
Confo Therapeutics Spin Off from VIB and Vrije Universiteit Brussel 15
Confo Therapeutics, Key Competitors 16
Confo Therapeutics, Key Employees 17

List of Figures
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Confo Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Confo Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Satair A/S:企業の戦略・SWOT・財務情報
    Satair A/S - Strategy, SWOT and Corporate Finance Report Summary Satair A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務情報
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • Kuoni Travel Holding Ltd.:企業のM&A・事業提携・投資動向
    Kuoni Travel Holding Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kuoni Travel Holding Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Reply S.p.A. (REY):企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • H.I.S. Co Ltd:企業の戦略・SWOT・財務分析
    H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Austevoll Seafood Asa:企業の戦略・SWOT・財務分析
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Immunomic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomic Therapeutics Inc (ITI) is a clinical-stage biotechnology company that develops patented lysosomal-associated membrane protein or lamp technology based nucleic acid immunotherapy platforms. The company’s vaccines utilize the body’s natural biochemistry to develop immune response inc …
  • British Broadcasting Corporation:戦略・SWOT・企業財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Welch Allyn Inc:企業の戦略的SWOT分析
    Welch Allyn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Hochschild Mining plc:企業のM&A・事業提携・投資動向
    Hochschild Mining plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hochschild Mining plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Shelby Energy Cooperative Inc:企業の戦略的SWOT分析
    Shelby Energy Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Petronas Dagangan Berhad (PETDAG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petronas Dagangan Bhd (Petronas Dagangan), a subsidiary of Petroliam Nasional Berhad, is an oil and gas company that retails and markets downstream oil and gas products. The company operates through its business segments such as retail, commercial, liquefied petroleum gas and lubricants. It …
  • Regulus Therapeutics Inc (RGLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • China Aerospace Science and Industry Corp:戦略・SWOT・企業財務分析
    China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Medpace Holdings Inc (MEDP):製薬・医療:M&Aディール及び事業提携情報
    Summary Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bio …
  • IVERIC bio Inc (ISEE):企業の財務・戦略的SWOT分析
    Summary IVERIC bio Inc (IVERIC bio) formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆